| 摘要 |
<p>In various aspects, the invention provides cell permeable Y-box binding protein-1 (YB-1) phosphorylation inhibitors, such as compounds comprising a peptidic sequence that is YB-1 selective protein kinase B (Akt) phosphorylation site. Compounds of the invention may take the form of peptide therapeutics for use, for example, in treating cancers.</p> |
